Request Deal Involvement
Alaska Permanent Fund, Altitude Life Science Ventures, and SoftBank Vision Fund 2 led a $230m Series B round in Tessera Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
White & Case
or
Principals
bidder
ALTITUDE LIFE SCIENCE VENTURES
bidder
SOFTBANK VISION FUND 2
bidder
ALASKA PERMANENT FUND CORPORATION
bidder
QATAR INVESTMENT AUTHORITY
target
TESSERA THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite